Aims: Increased pulse pressure (PP) is associated with increased cardiovascular mortality in haemodialysis (HD) patients. Autonomic imbalance is common in HD patients and predisposes to sudden cardiac death, but its relationship to PP is unknown. We investigated the relationship between cardiac autonomic modulation assessed by heart rate variability (HRV) and PP in HD patients. Methods: Continuous electrocardiograms recorded during HD sessions were repeated 5 times at 2-week intervals in stable HD patients. The high-frequency (HF) and low-frequency (LF) components and the LF/HF ratio of HRV were calculated during the first and last hour of the recordings. These values and the corresponding systolic blood pressure (SBP), diastolic blood pressure (DBP) and PP measurements were averaged in repeated recordings of each patient. Results: Seventy-six patients were included in the final analysis (aged 61 ± 15 years, 32% females, 37% diabetics). In male patients, LF/HF correlated inversely with pre- and post-HD PP (r = -0.369, p = 0.007 and r = -0.546, p = 0.000, respectively), positively with pre- and post-HD DBP (r = 0.358, p = 0.009 and r = 0.306, p = 0.028, respectively) and inversely with post-HD SBP (r = -0.350, p = 0.011). In female patients, LF/HF correlated positively with post-HD SBP (r = 0.422, p = 0.040). Conclusion: We observed an association between PP and HRV in male HD patients. Sex differences may be important for cardiac risk assessment.

Keywords:
Heart rate variability, Pulse pressure, Haemodialysis, Autonomic, Sex differences
1.
Annual Data Report, US Renal Data System. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012.
2.
Poulikakos D, Banerjee D, Malik M: Risk of sudden cardiac death in chronic kidney disease. J Cardiovasc Electrophysiol 2013;25:222-231.
3.
Wheeler DC, Becker GJ: Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 2013;83:377-383.
4.
Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, et al: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 2002;287:1548-1555.
5.
Briet M, Boutouyrie P, Laurent S, London GM: Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012;82:388-400.
6.
Casey DP, Curry TB, Joyner MJ, Charkoudian N, Hart EC: Relationship between muscle sympathetic nerve activity and aortic wave reflection characteristics in young men and women. Hypertension 2011;57:421-427.
7.
Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-1918.
8.
Palmer BF: Sexual dysfunction in uremia. J Am Soc Nephrol 1999;10:1381-1388.
9.
Poulikakos D, Malik M, Banerjee D: Parathyroid hormone and heart rate variability in haemodialysis patients. Nephron Clin Pract 2014;126:110-115.
10.
CardioDay®, Holter ECG Analysis Software, User Manual. Getemed Medizin- und Informationstechnik AG, 2006. Report No REF 90270-US 0505S1-LAB-Rev-C-GA-CardioDay-2-0-ENG_US.doc 12/16/2006.
11.
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043-1065.
12.
Arnold R, Kwai NC, Krishnan AV: Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies. Clin Neurophysiol 2013;124:2079-2090.
13.
Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW: Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 2005;20:1140-1147.
14.
Rodrigues FL, de Oliveira M, Salgado HC, Fazan R Jr: Effect of baroreceptor denervation on the autonomic control of arterial pressure in conscious mice. Exp Physiol 2011;96:853-862.
15.
Randall DC, Brown DR, Raisch RM, Yingling JD, Randall WC: SA nodal parasympathectomy delineates autonomic control of heart rate power spectrum. Am J Physiol 1991;260:H985-H988.
16.
Malik M, Camm AJ: Components of heart rate variability - what they really mean and what we really measure. Am J Cardiol 1993;72:821-822.
17.
Chrysohoou C, Skoumas J, Oikonomou E, Tsiachris D, Metaxa V, Lagoudakou S, et al: Aortic artery distensibility shows inverse correlation with heart rate variability in elderly non-hypertensive, cardiovascular disease-free individuals: the Ikaria Study. Heart Vessels 2013;28:467-472.
18.
Jaiswal M, Urbina EM, Wadwa RP, Talton JW, D'Agostino RB Jr, Hamman RF, et al: Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care 2013;36:2351-2358.
19.
Swierblewska E, Hering D, Kara T, Kunicka K, Kruszewski P, Bieniaszewski L, et al: An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens 2010;28:979-984.
20.
Hart EC, McBryde FD, Burchell AE, Ratcliffe LE, Stewart LQ, Baumbach A, et al: Translational examination of changes in baroreflex function after renal denervation in hypertensive rats and humans. Hypertension 2013;62:533-541.
21.
Brandt MC, Reda S, Mahfoud F, Lenski M, Bohm M, Hoppe UC: Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol 2012;60:1956-1965.
22.
Joannides R, Richard V, Moore N, Godin M, Thuillez C: Influence of sympathetic tone on mechanical properties of muscular arteries in humans. Am J Physiol 1995;268:H794-H801.
23.
Okada Y, Galbreath MM, Shibata S, Jarvis SS, VanGundy TB, Meier RL, et al: Relationship between sympathetic baroreflex sensitivity and arterial stiffness in elderly men and women. Hypertension 2012;59:98-104.
24.
Smetana P, Malik M: Sex differences in cardiac autonomic regulation and in repolarisation electrocardiography. Pflugers Arch 2013;465:699-717.
25.
Hart EC, Joyner MJ, Wallin BG, Charkoudian N: Sex, ageing and resting blood pressure: gaining insights from the integrated balance of neural and haemodynamic factors. J Physiol 2012;590:2069-2079.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.